Trial of IRE in Cholangiocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 5, 2018

Primary Completion Date

August 16, 2021

Study Completion Date

August 16, 2021

Conditions
Cholangiocarcinoma
Interventions
DEVICE

IRE Device

For use in ablating soft tissue

Trial Locations (7)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memoral Sloan Kettering Westchester (Consent and Follow Up), Harrison

11570

Memorial Sloan Kettering Nassau (Consent and Follow-up), Rockville Centre

11725

Memorial Sloan Kettering Commack (Consent and Follow up), Commack

07920

Memoral Sloan Kettering Basking Ridge (Consent and Follow up), Basking Ridge

07748

Memoral Sloan Kettering Monmouth (Consent and Follow up), Middletown

07645

Memorial Sloan Kettering Bergen (Consent and Follow up), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03769753 - Trial of IRE in Cholangiocarcinoma | Biotech Hunter | Biotech Hunter